Taichung

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Hepatitis B1 trial
• Pancreatic cancer1 trial

Phase

• Phase 22 trials

Status

• Completed2 trials

Lead sponsor

• Trishula Therapeutics, Inc.1 trial
• Vir Biotechnology, Inc.1 trial

Closed trials

• Completed

  Phase 2 Study of TTX-030 and Chemotherapy With or Without Budigalimab for 1L mPDAC Patients

  NCT06119217· Phase 2· Trishula Therapeutics, Inc.· Source

• Completed

  Study of VIR-2218, VIR-3434, and/or PEG-IFNα in Subjects With Chronic Hepatitis B Virus Infection

  NCT04856085· Phase 2· Vir Biotechnology, Inc.· Source